IGC PHARMA, INC. Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for the quarter ending 2018-12-31 was 27.13K shares.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for the quarter ending 2015-12-31 was 823.25K shares.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for the quarter ending 2015-09-30 was 250.00K shares.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for the quarter ending 2013-12-31 was 30.00K shares.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for fiscal 2019 was 107.13K shares.
- IGC PHARMA, INC. stock issued during period, shares, issued for services for fiscal 2016 was 50.00K shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2019-03-31 | 107.13K shares 10-K · filed 2019-06-14 | |
| 2018-12-31 | 27.13K shares 10-Q · filed 2019-02-12 | |
| 2016-03-31 | 50.00K shares 10-K · filed 2017-07-14 | |
| 2015-12-31 | 823.25K shares 10-Q · filed 2016-02-16 | |
| 2015-09-30 | 250.00K shares 10-Q · filed 2015-11-13 | |
| 2013-12-31 | 30.00K shares 10-Q · filed 2014-02-14 | |
| 2013-09-30 | 6.00K shares 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |